Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg 

Slides:



Advertisements
Similar presentations
Volume 62, Issue 4, Pages (October 2012)
Advertisements

Volume 68, Issue 2, Pages (August 2015)
Volume 57, Issue 1, Pages (January 2010)
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Testosterone Therapy in Men With Prostate Cancer
Global Trends in Testicular Cancer Incidence and Mortality
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 4, Pages (April 2008)
Volume 62, Issue 5, Pages (November 2012)
Volume 54, Issue 6, Pages (December 2008)
Volume 61, Issue 5, Pages (May 2012)
Volume 61, Issue 5, Pages (May 2012)
Prostate Cancer Epidemic in Sight?
Volume 65, Issue 6, Pages (June 2014)
Volume 61, Issue 3, Pages (March 2012)
Volume 63, Issue 4, Pages (April 2013)
Tumour Grade, Treatment, and Relative Survival in a Population-based Cohort of Men with Potentially Curable Prostate Cancer  Sam Ladjevardi, Gabriel Sandblom,
The Importance of Transurethral Resection in Managing Patients With Urothelial Cancer in the Bladder: Proposal for a Transurethral Resection of Bladder.
Volume 67, Issue 2, Pages (February 2015)
Measuring the Urologic Iceberg: Design and Implementation of the Boston Area Community Health (BACH) Survey  John B. McKinlay, Carol L. Link  European.
Volume 54, Issue 4, Pages (October 2008)
Elizabeth K. Bancroft, Rosalind A. Eeles
Volume 63, Issue 6, Pages (June 2013)
Ute Ganswindt, Arnulf Stenzl, Michael Bamberg, Claus Belka 
Prostate Cancer Detection: A View of the Future
Ongoing Gleason Grade Migration in Localized Prostate Cancer and Implications for Use of Active Surveillance  Adam B. Weiner, Ruth Etzioni, Scott E. Eggener 
Volume 68, Issue 3, Pages (September 2015)
Low-risk Prostate Cancer: Identification, Management, and Outcomes
Volume 63, Issue 5, Pages (May 2013)
Volume 69, Issue 3, Pages (March 2016)
Volume 60, Issue 4, Pages (October 2011)
Volume 73, Issue 4, Pages (April 2018)
Laurent Boccon-Gibod  European Urology Supplements 
Volume 53, Issue 4, Pages (April 2008)
Volume 73, Issue 2, Pages (February 2018)
Prostate Cancer Epidemic in Sight?
The Origin of the Bone Scan as a Tumour Marker in Prostate Cancer
Volume 61, Issue 6, Pages (June 2012)
Volume 53, Issue 4, Pages (April 2008)
Volume 74, Issue 2, Pages (August 2018)
Long-term Cancer-specific Survival in Patients with High-risk, Non–muscle-invasive Bladder Cancer and Tumour Progression: A Systematic Review  Sven van.
Shifting Paradigms for High-grade Prostatic Intraepithelial Neoplasia
Volume 71, Issue 1, Pages (January 2017)
Volume 65, Issue 6, Pages (June 2014)
Volume 68, Issue 4, Pages (October 2015)
Is It Necessary to Detect All Prostate Cancers in Men with Serum PSA Levels
Volume 62, Issue 6, Pages (December 2012)
Volume 50, Issue 5, Pages (November 2006)
CyberKnife in the Treatment of Prostate Cancer: A Revolutionary System
Volume 55, Issue 3, Pages (March 2009)
Prostate Cancer Nomograms: An Update
The Diverse Genomic Landscape of Clinically Low-risk Prostate Cancer
Volume 71, Issue 5, Pages (May 2017)
Testicular Cancer Variations in Time and Space in Europe
Heterogeneity in Definitions of High-risk Prostate Cancer and Varying Impact on Mortality Rates after Radical Prostatectomy  Matthew Mossanen, Kenneth.
Volume 59, Issue 4, Pages (April 2011)
Volume 75, Issue 3, Pages (March 2019)
European Urology is “Your” Journal
Volume 74, Issue 6, Pages (December 2018)
Prostate Cancer Screening Decreases the Absolute Risk of Being Diagnosed with Advanced Prostate Cancer—Results from a Prospective, Population-Based Randomized.
Role of Transurethral Resection of the Prostate and Biopsy of the Peripheral Zone in the Same Session after Repeated Negative Biopsies in the Diagnosis.
The Comparability of Models for Predicting the Risk of a Positive Prostate Biopsy with Prostate-Specific Antigen Alone: A Systematic Review  Fritz Schröder,
Volume 52, Issue 6, Pages (December 2007)
Volume 68, Issue 2, Pages (August 2015)
Edith Canby-Hagino, Javier Hernandez, Timothy C. Brand, Ian Thompson 
Volume 53, Issue 2, Pages (February 2008)
Volume 74, Issue 6, Pages (December 2018)
Volume 54, Issue 3, Pages (September 2008)
Volume 54, Issue 1, Pages (July 2008)
Volume 51, Issue 5, Pages (May 2007)
Presentation transcript:

The CAPRA Score at 10 Years: Contemporary Perspectives and Analysis of Supporting Studies  Jonathan S. Brajtbord, Michael S. Leapman, Matthew R. Cooperberg  European Urology  Volume 71, Issue 5, Pages 705-709 (May 2017) DOI: 10.1016/j.eururo.2016.08.065 Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 1 CAPRA score. pos bx=positive biopsy; PSA=prostate-specific antigen. European Urology 2017 71, 705-709DOI: (10.1016/j.eururo.2016.08.065) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 2 CAPRA-S score. ECE=extracapsular extension; LNI=lymph node involvement; SM=surgical margin; SVI=seminal vesicle invasion; PSA=prostate-specific antigen. European Urology 2017 71, 705-709DOI: (10.1016/j.eururo.2016.08.065) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 3 J-CAPRA score. PSA=prostate-specific antigen. European Urology 2017 71, 705-709DOI: (10.1016/j.eururo.2016.08.065) Copyright © 2016 European Association of Urology Terms and Conditions

Fig. 4 Implementation of a Cancer of the Prostate Risk Assessment (CAPRA) calculator within an Epic SmartForm. CAPRA=Cancer of the Prostate Risk Assessment; PSA=prostate-specific antigen. European Urology 2017 71, 705-709DOI: (10.1016/j.eururo.2016.08.065) Copyright © 2016 European Association of Urology Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2024 SlidePlayer.com. Inc. All rights reserved.